欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）

MR编号	NL/H/3854/003
药品名称	Aprepitant Teva 125mg/80 mg, hard capsules
活性成分	aprepitant 80.0 mg aprepitant 125.0 mg
剂型	Capsule, hard
上市许可持有人	Teva B.V. Swensweg 5 2031 GA HAARLEM The Netherlands
参考成员国 - 产品名称	Netherlands (NL) Aprepitant Teva 125mg/80mg harde capsules
互认成员国 - 产品名称	Germany (DE) Aprepitant-ratiopharm 125 mg/80 mg Hartkapseln Belgium (BE) Aprepitant Teva 125 mg + 80 mg harde capsules Austria (AT) Aprepitant ratiopharm 80 mg/125 mg Hartkapseln France (FR) Italy (IT) Poland (PL) Czechia (CZ) Aprepitant Teva Slovenia (SI) Croatia (HR) Aprepitant Teva 125 mg + 80 mg tvrde kapsule
许可日期	2018/05/31
最近更新日期	2023/10/11
药物ATC编码	A04AD12 aprepitant
申请类型	TypeLevel1：Abridged TypeLevel2：Additional Strength/Form TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC TypeLevel4：Chemical Substance TypeLevel5：Prescription Only
附件文件下载	Final SPC \| 1.3.1 spc-eu trackedDate of last change:2021/03/08 Final SPC \| 1.3.1 spc-eu cleanDate of last change:2021/03/08 PAR Summary \| 181127 NL.H.3854.001-003.DC Aprepitant Teva summary ENDate of last change:2018/12/06 PAR \| 181205 NL.H.3854.001-003.DC Aprepitant Teva PARDate of last change:2018/12/06 Final Product Information \| 1.3.1-label-inner-aprepitant-common-cleanDate of last change:2018/10/18 Final Product Information \| 1.3.1 aprepitant-125mg&80mg-spc-common-cleanDate of last change:2018/10/18 Final Product Information \| 1.3.1 pil-common-cleanDate of last change:2018/10/18 Final Product Information \| 1.3.1-label-outer-aprepitant-common-cleanDate of last change:2018/10/18
市场状态	Positive